These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9294660)
1. Risk stratification for malignant arrhythmias after myocardial infarction. A reappraisal in the era of thrombolysis. González-Hermosillo González JA Arch Inst Cardiol Mex; 1997; 67(3):183-5. PubMed ID: 9294660 [No Abstract] [Full Text] [Related]
2. New methods for risk stratification in patients after myocardial infarction autonomic control and substrate sensitivity. Sleight P J Am Coll Cardiol; 2007 Dec; 50(24):2291-3. PubMed ID: 18068037 [No Abstract] [Full Text] [Related]
4. [Risk stratification after myocardial infarct]. Hombach V; Osterhues HH; Höher M; Scharf B; Kochs M Z Kardiol; 2000; 89 Suppl 3():75-86. PubMed ID: 10810789 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification after acute myocardial infarction: which studies are best? Figueredo VM Postgrad Med; 1996 Apr; 99(4):207-14. PubMed ID: 8604407 [TBL] [Abstract][Full Text] [Related]
6. [The predictors of myocardial electrical instability after its infarction and thrombolytic therapy]. Chernetsov VA Voen Med Zh; 2000 Mar; 321(3):27-31. PubMed ID: 10815535 [No Abstract] [Full Text] [Related]
7. Autonomic function following myocardial infarction. Turner A; Malik M; Camm AJ Br J Hosp Med; 1994 Feb 2-15; 51(3):89-96. PubMed ID: 8193847 [TBL] [Abstract][Full Text] [Related]
8. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects]. Popov VV; Kopitsa NP; Oparin AL Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353 [No Abstract] [Full Text] [Related]
9. [Comparison of the prevalence of non-invasive risk markers of the sudden cardiac death in patients treated by thrombolysis and by percutaneous transluminal coronary angioplasty]. Krivan L; Kozák M; Sepsi M; Lokaj P; Honziková N; Spinar J Cas Lek Cesk; 2005; 144(8):546-8; discussion 548-9. PubMed ID: 16173609 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification of patients post-myocardial infarction. Densem CG; Lee HS Br J Hosp Med; 1997 Jun 18-Jul 8; 58(1):32-5. PubMed ID: 9337917 [No Abstract] [Full Text] [Related]
11. Use of beta-blockers during and after myocardial infarction. Aronow WS Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097 [TBL] [Abstract][Full Text] [Related]
12. Assessment of T-wave alternans for arrhythmic risk stratification after myocardial infarction: is it useful in all patients? de Sousa J Rev Port Cardiol; 2006 Apr; 25(4):389-94. PubMed ID: 16869204 [No Abstract] [Full Text] [Related]
13. [Neoton and thrombolytic therapy of myocardial infarction]. Perepech NB; Nedoshivin AO; Nesterova IV Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083 [TBL] [Abstract][Full Text] [Related]
14. Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Wichterle D; Simek J; La Rovere MT; Schwartz PJ; Camm AJ; Malik M Circulation; 2004 Sep; 110(10):1183-90. PubMed ID: 15313954 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of heart rate variability after acute myocardial infarction. Balanescu S; Corlan AD; Dorobantu M; Gherasim L Med Sci Monit; 2004 Jul; 10(7):CR307-15. PubMed ID: 15232505 [TBL] [Abstract][Full Text] [Related]